Moderna (MRNA) ROE US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
ROE, % ? 86.3% 43.7% -34.0% -32.7% -32.6%   -43.1%  
Changes by years, y/y, % +115pp -43pp -78pp +1pp +0pp     +2.3%

Moderna. ROE, %

Moderna. ROE, changes, pp

Moderna (MRNA) ROE US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
ROE, % ? -33.3% -30.9% -33.4% -32.6% -43.1%   -43.1%
Changes by years, y/y, % +13pp +19pp -15pp +0pp -10pp    
Changes by quarters, q/q, % -1pp +2pp -3pp +1pp -10pp    

Moderna. ROE, %

Moderna. ROE, changes, pp

Moderna. ROE, changes, pp